178 filings
Page 3 of 9
8-K
l8d smbz832hehyf6azo
25 May 22
Submission of Matters to a Vote of Security Holders
5:20pm
8-K
t0hrrg 0lm4
6 May 22
Intercept Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
7:16am
8-K
iexoqrwwj1ca9fpq
5 May 22
Entry into a Material Definitive Agreement
7:16am
8-K
4xjosadoxdbwqa
2 Mar 22
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results, Issues 2022 Financial Guidance and Provides Business Update
8:00am
8-K
xex8cf17nxsslg6n0
9 Feb 22
Entry into a Material Definitive Agreement
4:01pm
8-K
krh64caw2wegh
7 Feb 22
Other Events
4:36pm
8-K
38hgeve
7 Feb 22
Other Events
4:01pm
8-K
qcj7mlexlgtjnvl bho
31 Jan 22
Departure of Directors or Certain Officers
4:01pm
8-K
jmf 503j1zn
10 Jan 22
Departure of Directors or Certain Officers
4:01pm
8-K
qxxdb64x6f grk
20 Dec 21
Intercept Pharmaceuticals Provides Update on Phase 3 REVERSE Trial in Compensated Cirrhosis Due to NASH
8:05am
8-K
3vkojdq1btciks9jiwht
9 Dec 21
Intercept Announces Withdrawal of EMA Marketing Authorization Application for Obeticholic Acid for Advanced Liver Fibrosis Due to NASH
7:00am
8-K
23vpzqf20lbicfiru
3 Nov 21
Intercept Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
7:16am
8-K/A
38o17l6krdxaf qlbt
22 Oct 21
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
wgehkt6uf8n
23 Aug 21
Entry into a Material Definitive Agreement
4:31pm
8-K
nfo0bvaxp4 09onlgei
11 Aug 21
Intercept Pharmaceuticals Announces Convertible Notes Exchange, New Issuance and Stock Repurchase
8:08am
8-K
qumgnkp6c6s 07
29 Jul 21
Intercept Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
7:16am
8-K
oa0 zadhrc6
7 Jun 21
Intercept Appoints Andrew Saik as Chief Financial Officer
8:15am
8-K
2qy72flsn
27 May 21
Departure of Directors or Certain Officers
4:31pm
8-K
bu7e 7g55
26 May 21
Intercept Announces Updated Ocaliva® (obeticholic acid) U.S. Prescribing Information
5:21pm
8-K
8qbhfqt
6 May 21
Intercept Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
7:16am